Suvretta Capital Management, LLC Chimerix Inc Transaction History

Suvretta Capital Management, LLC

  • $2.39 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.34 - $5.34 $3.36 Million - $13.4 Million
2,505,077 Added 90.55%
5,271,696 $11 Million
Q4 2021

Feb 14, 2022
BUY
$5.23 - $7.18 $4.49 Million - $6.17 Million
858,999 Added 45.03%
2,766,619 $17.8 Million
Q3 2021

Nov 15, 2021
BUY
$5.94 - $8.75 $6.43 Million - $9.47 Million
1,082,379 Added 131.16%
1,907,620 $11.8 Million
Q2 2021

Aug 16, 2021
SELL
$7.54 - $9.79 $678,773 - $881,325
-90,023 Reduced 9.84%
825,241 $6.6 Million
Q1 2021

May 17, 2021
BUY
$4.76 - $11.25 $4.36 Million - $10.3 Million
915,264 New
915,264 $8.82 Million

Others Institutions Holding CMRX

# of Institutions
81
Shares Held
36.8M
Call Options Held
72.2K
Put Options Held
169K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email